• Users Online: 233
  • Print this page
  • Email this page


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2021  |  Volume : 33  |  Issue : 1  |  Page : 41-47

Patient satisfaction of intravitreal bevacizumab injection services at a referral center


1 Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science; Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science; Department of Ophthalmology, Torfeh Medical Center, Shahid Beheshti University of Medicine Sciences, Tehran, Iran
4 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Date of Submission29-Mar-2020
Date of Decision19-Jun-2020
Date of Acceptance11-Jul-2020
Date of Web Publication26-Mar-2021

Correspondence Address:
Saeed Karimi
Department of Ophthalmology, Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JOCO.JOCO_116_20

Rights and Permissions
  Abstract 

Purpose: To evaluate the patient satisfaction of intravitreal bevacizumab (IVB) injection services for ocular complications of diabetes mellitus (DM) at a referral center.
Methods: Patients with diabetic macular edema (DME) and diabetic retinopathy (DR) who had undergone IVB injections between March and September 2018 were interviewed by telephone using two questionnaires. First, demographic information, medical history, and the Patient Satisfaction Questionnaire Short Form (PSQ-18) 5-point scale were collected. Then, the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ) 7-point scale was completed. Total scores are presented on a 100-point scale, with 100 indicating complete satisfaction.
Results: Two hundred and fifty patients (145 with DME and 105 with DR) were interviewed (mean age: 61 ± 10 years; male-to-female ratio: 1:1.5). The response rate was 96%. Twenty-one patients had only one injection. Two hundred and forty-eight (99.2%) patients had insurance. The mean number of total injections was 12.2 ± 11.5. Seventy (28%), forty-seven (18.8%), sixty-one (24.4%), and seventy-two (28.8%) patients underwent IVB treatment for <6 months, between 7 and 12 months, between 13 and 24 months, and >25 months, respectively. The mean total and overall scores were 90.8 ± 22.5 (completely satisfied) and 88.7 ± 16.6 (completely satisfied) based on PSQ-18 and RetTSQ, respectively. Financial problems and appointment scheduling systems were the highest cases of dissatisfaction.
Conclusion: The majority of patients were highly satisfied with IVB injections for the management of ocular complications of DM. The appointment taking procedure, waiting times, out-of-pocket expenses, and access to the hospital should be improved.

Keywords: Diabetic retinopathy, Intravitreal injections, Macular edema, Patient satisfaction


How to cite this article:
Shayan M, Safi S, Karimi S, Yaseri M. Patient satisfaction of intravitreal bevacizumab injection services at a referral center. J Curr Ophthalmol 2021;33:41-7

How to cite this URL:
Shayan M, Safi S, Karimi S, Yaseri M. Patient satisfaction of intravitreal bevacizumab injection services at a referral center. J Curr Ophthalmol [serial online] 2021 [cited 2021 Apr 18];33:41-7. Available from: http://www.jcurrophthalmol.org/text.asp?2021/33/1/41/312158


  Introduction Top


Severe non-proliferative diabetic retinopathy (DR), proliferative DR, and diabetic macular edema (DME) are the leading causes of visual impairment and blindness in the working-age population.[1],[2],[3],[4]

Anti-vascular endothelial growth factor (anti-VEGF) is one of the most important agents for treating retinal vascular diseases, including DME and DR.[5],[6],[7] Intravitreal anti-VEGF is the first choice for treating and preventing the progression of retinal diseases with neovascularization and retinal and choroidal leakage.[8],[9],[10] Bevacizumab (Avastin®; Genentech, Inc., South San Francisco, CA, USA) is a humanized monoclonal antibody that blocks the VEGF. After the study by Rosenfeld et al. in 2005 regarding the effect of bevacizumab in a patient with age-related macular degeneration (AMD), intravitreal bevacizumab (IVB) became popular in the ophthalmology field.[11],[12],[13],[14]

Three strategies are currently being used for IVB injection management: (a) 4–6-week intervals (b) injecting when necessary (pro re nata [PRN]) and (c) treat and extend, progressively increasing the intervals during the treatment.[15],[16] Patients may still feel anxious and stressed during the procedure even though the safety and effectiveness of intravitreal injections have been proven. In previous studies, pain reduction strategies such as changing the form of anesthesia, adjusting the needle gauze size, playing music, and comforting the patient during the injection have been investigated.[17] It is important to consider strategies that can improve patient satisfaction.

There is little information available about patient satisfaction, even though the number of patients that require intravitreal injections is increasing, and every individual needs more than one injection each year. This study aimed to evaluate the patient satisfaction of intravitreal injection services at a tertiary eye care hospital in Iran for patients with diabetic ocular complications.


  Methods Top


In this cross-sectional study, all patients with DR or DME who had received IVB injections at Torfeh Medical Center between March and September 2018 were interviewed. Two trained interviewers conducted interviews over the telephone. The average duration of each interview was 15–20 min. The telephone interview was conducted using two questionnaires. First, the demographic information, medical history, and Patient Satisfaction Questionnaire Short Form (PSQ-18) 5-point scale (1 = strongly agree, 5 = strongly disagree) was completed. Then, the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ) 7-point scale (6 = very satisfied, 0 = very dissatisfied) was completed. All satisfaction scores were standardized on a 0–100 scale, with a score of 100 representing the highest level of satisfaction. The satisfaction spectrum was divided into five categories: (1) completely satisfied (80–100%), (2) satisfied (60–80%), (3) somewhat satisfied (40–60%), (4) dissatisfied (20–40%), and (5) completely dissatisfied (0–20%). Some aspects of the PSQ-18, such as patient satisfaction, including general skills of the medical staff, physicians' manners, quality of verbal communications, cost of treatment, overall satisfaction with the treatment course, availability of the physicians, and waiting times were not specifically considered in the RetTSQ.[18]

RetTSQ consists of two subscales: subscale one examines the positive aspects of treatment like current satisfaction, whether the treatment worked well, the influence of patients' decision on treatment planning, safety of the treatment, information provided about the treatment, encouragement of others, and whether the injections were continued. Subscale two of the RetTSQ examines the negative aspects of treatment, such as side effects, pain, discomfort, unpleasant feelings, any difficulties, apprehensiveness, and time.[19]

Based on the pilot phase of the study, we observed that the appointment scheduling system and the waste of time – specifically in the financial section and the waiting room before injection – were the sources of concern for our patients. Hence, we decided to ask these questions separately to have a better understanding of these problems. In the original format of the PSQ-18 questionnaire, these factors were evaluated under the general term of accessibility and convenience.

General information of patients was extracted from medical records. Furthermore, to establish a positive connection with patients, as well as verifying the information, some of this information was asked again during the interview.

As well as reliability, the validity of the contents of the Persian translation of the questionnaires was validated in several interviews with physicians, patients, and their companions at the pilot phase of this study. Previous studies that used these questionnaires also confirmed the content validity and reliability.[20],[21]

All aspects of this study that involved patients were conducted with their approval. Informed consent was verbally received from all patients before the interview, and none of the answers affected their treatment. The study protocol was approved by the Ethical Committee at Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences (Ethical approval code: IR.SBMU.ORC.REC.1397.38). All procedures performed in this study were in accordance with the Helsinki Declaration of 1975, as revised in 2000.

The collected information was analyzed using SPSS (IBM Corp. Released in 2017. IBM SPSS Statistics for Windows, version 25.0. Armonk, NY, USA: IBM Corp.). Data are presented with the mean, standard deviation, frequency, and percentage. The reliability of the mean score estimates was assessed by 95% confidence interval. To compare the quality scores among the various demographic variables, we used the t-test and one-way analysis of variance. These relationships were also evaluated using an analysis of covariance. In addition, we used Pearson's correlation coefficient to examine the relationship between the satisfaction scores of the dimensions and the total satisfaction scores. A value of P < 0.05 was considered statistically significant.


  Results Top


Demographic and clinical characteristics of the patients

Two hundred and fifty patients with DR and DME were included in this study. Of these, 145 patients had been diagnosed with DME and 105 with DR (90 patients with proliferative DR and 15 patients with non-proliferative DR). The overall response rate was 96%. Twenty-one patients only had one injection, while the other patients had more than one injection. The mean age was 61 ± 10 years. Ninety-seven (38.8%) patients were male, and 153 (61.2%) patients were female. Two hundred and forty-eight (99.2%) patients had insurance. The mean number of total injections was 12.2 ± 11.5 injections with 6.9 ± 5.8 and 7 ± 6.3 injections in the right and left eye, respectively. In 188 (75.2%) individuals, both eyes were affected, and the patients received bilateral injections. Seventy (28%), 47 (18.8%), 61 (24.4%), and 72 (28.8%) of the patients underwent IVB treatment for <6 months, between 7 and 12 months, between 13 and 24 months, and >25 months, respectively. Fifty-three (21.2%) patients were illiterate. Four (1.6%) patients had a physical disability due to other diabetes-related complications. One hundred and seventy-one (68.4%) individuals were residents of the capital city in which the hospital was located, and 79 (31.6%) patients were residents of other districts. In terms of the type of transport, 170 (68%) of the patients did not own a personal vehicle and used public transportation, whereas 74 (29.6%) and 6 (2.4%) patients used a personal car and motorcycle, respectively. All the patients' characteristics are summarized in [Table 1].
Table 1: Demographic characteristics, duration of diabetes, and number of injections

Click here to view


Patient satisfaction based on Patient Satisfaction Questionnaire-18

The mean total score for the general satisfaction of the intravitreal injection services was 90.8 ± 22.5 (completely satisfied) based on PSQ-18. In addition, technical quality, interpersonal manner, communication, financial aspects, time spent with the doctor, accessibility, and convenience were examined. The significance of demographic variables was analyzed and is presented in [Table 2]. The factors that were a source of complaint, for example, wasted time in the payment process, wasted time while waiting for their turn, and the appointment taking procedure were considered separately. The satisfaction score domains for each group are displayed in [Table 3]. The correlations between each domain were also evaluated and are presented in [Table 4].
Table 2: General satisfaction scores based on demographics and other variables

Click here to view
Table 3: Patients' satisfaction of intravitreal injection based on patient satisfaction questionnaire short form

Click here to view
Table 4: Correlation of each aspect and general satisfaction

Click here to view


Patient satisfaction based on Retinopathy Treatment Satisfaction Questionnaire

The mean total score for treatment with intravitreal injections was 88.7 ± 16.6 (completely satisfied) based on RetTSQ. The mean total score for each subscale in RetTSQ was as follows, 90.6 ± 17.6 (completely satisfied) for subscale one and 86.4 ± 21.4 (completely satisfied) for subscale two.

The satisfaction of patients based on the diagnosis of the ocular problems (proliferative DR, non-proliferative DR, and DME) was analyzed, and the results are displayed in [Table 5].
Table 5: Satisfaction scores based on the diagnosis

Click here to view



  Discussion Top


Intravitreal injections for preserving eyesight involve regular follow-up visits and a great deal of time and money. Even though the participants were satisfied with both the service and their treatment, financial problems were a limitation. In this survey, the financial aspect scored 74.9 ± 36.1, which was the lowest score of all of the PSQ-18 domains. Satisfaction with the financial aspects did not correlate with general satisfaction in this study. As such, overall satisfaction can be high, while financial satisfaction is low. Interestingly, satisfaction with the financial aspects was related to the socioeconomic position of the patients. In Iran, the cost of each injection is equivalent to half of the minimum wage salary based on the reports published by the statistical center of Iran. Besides, insurance covers approximately half of the cost. Therefore, the reported results could be due to the high expense of the intravitreal injections in our country. By having full insurance coverage and facilitating access to public transportation, the financial burden can be reduced, and patients may be more likely to attend follow-up sessions.

Although nearly all patients (99.9%) had insurance, financial problems were still a major cause of patient dissatisfaction. This could be related to other medical expenses, such as some prescriptions or procedures that were not covered by the insurance or the cost of accommodation or transportation. Several suggestions could help overcome these financial problems. Insurance companies should devise diverse and affordable plans designed explicitly for the needs of families or individuals. Reasonably priced accommodation options nearby medical centers should be made available for relatives or patients who require follow-up visits.

Patients' resentment at medical bills can adversely affect their overall satisfaction with the medical services received. Health-care organizations should create new methods for explaining the treatment cost and payment plans to patients. Patients are often overwhelmed with the complicated payment process. Medical expenses should be explained in simple and easy-to-understand language. Patients should be informed about any potential charges of the medical services they receive, alternative treatment options, and the out-of-pocket expenses. Health-care services or insurance companies should make the patients aware of the medical expenses that are and are not covered by their health insurance. This information should be discussed with the patient before treatment. It is worth mentioning that some patients struggle with the high therapeutic cost of their treatment. Patient satisfaction could be improved if the health care organizations provided alternative payment strategies, for example, payable installments or low-interest loans. A positive experience with payment methods could immensely increase patient satisfaction.[22],[23]

RetTSQ questionnaire is a disease-specific questionnaire: the items included in this questionnaire are related to diagnosis and treatment. The patient satisfaction based on RetTSQ was high in all the aspects; therefore, the scores of each item was not reported separately. To inspect the other factors affecting patient satisfaction, we used the PSQ-18 questionnaire. The items included in PSQ-18 are more general and contain most of the factors associated with patient satisfaction.

The PSQ-18 items that were a source of concern for patients have been individually evaluated. Time wasted in the payment process, waiting for their turn, and the appointment scheduling through the telephone or website were the highest causes of dissatisfaction. The appointment scheduling mean score was lower compared to other domains. This may be improved through enhancing the appointment system and minimizing the waiting times.

The appointment scheduling system is of utmost importance in enhancing patient satisfaction as it is the first time patients interact with the health-care system. An inefficient system can result in patients presenting to the wrong service, forcing them to return at another time. A disorganized system wastes a lot of time and money both for patients and health-care providers. Different types of appointment scheduling techniques such as phone call centers, automated call centers, short message services, and website bookings should be made available. Web-based appointment taking systems are increasingly popular with patients. These should be developed using an accessible platform with an easy interface. The benefits of the online website/mobile applications are no human errors, time-saving, increased variability of available physicians and available times, flexibility in changing the appointment time, reduction of waiting time, decreasing staff workload, reducing non-attendance, and balancing the number of patients in each visit.[24],[25]

It should be noted that a number of elderly patients are not familiar with new web-based appointment taking systems. Hence, other appointment taking options should still be made available. Educating patients about how to use applications or websites could also be considered. Furthermore, 21% of our patients were illiterate, and hence, the interface of appointment scheduling systems and also the informative brochures for patients should be more graphical.

Many patients miss their appointments due to transportation issues. Affordable and accessible transportation can also positively affect the health-care system. It will decrease the number of patients that do not present to their appointments and reduce the rate of non-adherence as well as the financial burden on patients and health insurance companies. Some suggestions with regard to alleviating patient discomfort are as follows. As 68% of our patients did not own a personal vehicle, public transportation should be available from any area in the city to every medical center. Available parking spots for patients who come with their personal vehicles should be made available. For patients with significant visual impairment, the elderly, or people with disabilities, ambulance transportation should be offered. Since 31% of the patients were residents of other districts, the development of medical centers to address related eye problems in other remote areas, not only in capital cities, should be considered. While improving transportation requires the development of infrastructure, health-care centers could help by highlighting this issue to the relevant stakeholders.[26],[27]

Patient satisfaction with the quality of care provided by the ophthalmology residents of North Carolina Hospital, the United States of America, was investigated using the PSQ-18. The reported satisfaction rate was higher than 80%.[28] In other similar studies with different types of questionnaires, patients were satisfied with the injection services and were willing to continue their treatments.[29],[30]

A study that investigated the burden of repetitive intravitreal injections on patients with AMD reported that the most significant psychosocial factors for patients were anxiety before the injection, pain during the treatment, cost of the treatment, transportation, and priorities of the treatment schedule over any other plans. These ranged from slight to significant burdens.[31]

Treatment satisfaction in myopic choroidal neovascularization was investigated during consecutive months (0, 1, 6, and 12 months). Over the assessment period, the patient's treatment satisfaction significantly increased. This could be because patients with good compliance experienced more improvement in their vision, and therefore, higher future satisfaction.[32]

Another method of intravitreal injection was evaluated in Great Western Hospital in the United Kingdom. In the mentioned study, intravitreal injections were performed by a trained team of five nurses. Patients were followed for 1 month, and a locally designed questionnaire was filled out. The feedback of the patients was highly positive. Anxiety and nervousness were the two main symptoms that were noticed. Although patients provided highly positive feedback regarding the intravitreal injections performed by nurses, some patients were anxious that the nurse administering injections would be unsafe.[33] The education of patients might reduce these concerns and help them adapt conveniently with the new method of injection. The preferences of patients, for example, the location that the injections are performed, cleanliness of the utilities, waiting time, informed about the procedure, accessibility, and convenience, can also affect patient satisfaction.[34] Strategies for increasing the convenience for patients have been reported based on the priorities of patients disaggregated by gender.[17]

A diagnosis-based satisfaction score in our patients did not reveal any significant difference between the proliferative DR, non-proliferative, or the DME patients in terms of satisfaction. The correlation of each aspect of the PSQ questionnaire with general satisfaction was investigated. The most important factors contributing to the general satisfaction of patients were physicians' manners, communication skills, average time spent, accessibility and convenience, technical aspects, and the quality of care. Besides, a significant statistical association was shown between the total number of injections and the satisfaction rate based on RetTSQ. This could be due to patient familiarity with the treatment procedure.

The results of this article showed that a good patient–doctor relationship positively impacted general satisfaction. This suggests that although each domain is important for patient satisfaction, this domain may compensate for the deficit of other domains.

Ever-changing technological advancements suggest that the future of healthcare is going to be integrated with technology. The positive impacts of an integrated platform based on the electronic health record (EHR) on different aspects of patient satisfaction are discussed below. An EHR stores all the patients' demographic information, medical history, drug history, laboratory test results, and radiological imaging.[35]

We suggest that policymakers use an EHR to overcome many problems regarding medical care services. The EHR of patients should be accessible in all hospitals and clinics through a cyber-platform/mobile-application. Researchers state that excessive clinical workload would lead to medical errors and suboptimal patient care.[36] An EHR would undoubtedly help improve the quality of health-care services.[37] With all the patient medical history, the app could be used to help triage prospective patients by suggesting hospitals/clinics that are specialized in the required field. The EHR could be equipped with an online consulting system for discussing the severity of a patient's situation and confirming whether they need to visit in-person. If a doctor's visit is necessary, then the appointment could be scheduled through the EHR platform as well. This function avoids unnecessary visits. Therefore, the workload of health-care specialists, medical expenses of patients, and the pressure on health insurance would be reduced. Adherence to treatment is crucial in shaping clinical outcomes. The EHR could also be used to send reminders of upcoming appointments and follow-up visits to patients.

To our knowledge, this is the first study that evaluates patient satisfaction of intravitreal injection services based on both general satisfaction and treatment satisfaction. This study could be useful as a statistical analysis of patient satisfaction to enhance the quality of services received.

A larger sample size from different settings is required to achieve more findings regarding the factors that can have a negative impact on patients' satisfaction with IVB services.

In conclusion, the majority of patients were satisfied with the IVB injection service for the management of ocular complications of diabetes mellitus. The appointment-taking procedure and waiting times should be improved. In addition, full insurance coverage for diabetic patients and easy access to public transportation could also help reduce the burden of long-term treatment.

Acknowledgment

We acknowledge the Information Technology Unit of Torfeh Medical Center. Maryam Shayan and Sare Safi contributed equally to this work.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-36.  Back to cited text no. 1
    
2.
Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290:2057-60.  Back to cited text no. 2
    
3.
Jeganathan VS, Wang JJ, Wong TY. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care 2008;31:1905-12.  Back to cited text no. 3
    
4.
Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27:2540-53.  Back to cited text no. 4
    
5.
Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2014. DOI: 10.1002/14651858.CD005139.pub4.  Back to cited text no. 5
    
6.
Braithwaite T, Nanji AA, Lindsley K, Greenberg PB. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database Syst Rev 2014. DOI: 10.1002/14651858.CD007325.pub3.  Back to cited text no. 6
    
7.
Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 2014. DOI: 10.1002/14651858.CD007419.pub4.  Back to cited text no. 7
    
8.
Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: A report by the American Academy of Ophthalmology. Ophthalmology 2008;115:1837-46.  Back to cited text no. 8
    
9.
Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol 2012;2012:852183.  Back to cited text no. 9
    
10.
Velez-Montoya R, Oliver SC, Olson JL, Fine SL, Quiroz-Mercado H, Mandava N. Current knowledge and trends in age-related macular degeneration: Genetics, epidemiology, and prevention. Retina 2014;34:423-41.  Back to cited text no. 10
    
11.
Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005;112:1035-47.  Back to cited text no. 11
    
12.
Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-5.  Back to cited text no. 12
    
13.
Ziemssen F, Sobolewska B. Therapeutic efficacy of bevacizumab for age-related macular degeneration: What are the implications of CATT for routine management? Drugs Aging 2011;28:853-65.  Back to cited text no. 13
    
14.
Jansen RM. The off-label use of medication: The latest on the Avastin-Lucentis debacle. Med Law 2013;32:65-77.  Back to cited text no. 14
    
15.
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results. Ophthalmology 2012;119:1388-98.  Back to cited text no. 15
    
16.
Berg K, Hadzalic E, Gjertsen I, Forsaa V, Berger LH, Kinge B, et al. Ranibizumab or bevacizumab for neovascular age-related macular degeneration according to the lucentis compared to avastin study treat-and-extend protocol: Two-year results. Ophthalmology 2016;123:51-9.  Back to cited text no. 16
    
17.
Gomez J, Koozekanani DD, Feng AZ, Holt M, Drayna P, Mackley MR, et al. Strategies for improving patient comfort during intravitreal injections: Results from a survey-based study. Ophthalmol Ther 2016;5:183-90.  Back to cited text no. 17
    
18.
Grant N. Marshall RD. Scoring Instructions for the PSQ-18; 1993. Available from: https://www.rand.org/health-care/surveys_tools/psq.html. [Last accessed on 2018 Mar 01].].  Back to cited text no. 18
    
19.
Brose LS, Bradley C. Psychometric development of the retinopathy treatment satisfaction questionnaire (RetTSQ). Psychol Health Med 2009;14:740-54.  Back to cited text no. 19
    
20.
Dabaghian F, Khadem E, Ghods R. Evaluation of patient satisfaction with medical services at traditional Iranian medicine clinics in Tehran. J Patient Safety Quality Improve 2016;4:313-9.  Back to cited text no. 20
    
21.
Zahednezhad H, Poursharifi H, Babapour J. Relationship betweeh health locus of control, memory, and physician – Patient relationship with satisfaction of treatment in type II diabetic patients. UNMF 2011;9:2621-4.  Back to cited text no. 21
    
22.
Shan L, Li Y, Ding D, Wu Q, Liu C, Jiao M, et al. Patient satisfaction with hospital inpatient care: Effects of trust, medical insurance and perceived quality of care. PLoS One 2016;11:e0164366.  Back to cited text no. 22
    
23.
Pan J, Liu D, Ali S. Patient dissatisfaction in China: What matters. Soc Sci Med 2015;143:145-53.  Back to cited text no. 23
    
24.
Zhao P, Yoo I, Lavoie J, Lavoie B, Simoes E. Web-based medical appointment systems: A systematic review. J Med Internet Res 2017;19:E134.  Back to cited text no. 24
    
25.
Cao W, Wan Y, Tu H, Shang F, Liu D, Tan Z, et al. A web-based appointment system to reduce waiting for outpatients: A retrospective study. BMC Health Serv Res 2011;11:318.  Back to cited text no. 25
    
26.
American Hospital Association. Transportation and the Role of Hospitals; 2017. Available from: https://www.aha.org/transportation-and-role-hospitals. [Last accessed 2018 Mar 02].  Back to cited text no. 26
    
27.
Hains IM, Marks A, Georgiou A, Westbrook JI. Non-emergency patient transport: What are the quality and safety issues? A systematic review. Int J Qual Health Care 2011;23:68-75.  Back to cited text no. 27
    
28.
Jagadeesan R, Kalyan DN, Lee P, Stinnett S, Challa P. Use of a standardized patient satisfaction questionnaire to assess the quality of care provided by ophthalmology residents. Ophthalmology 2008;115:738-43.  Back to cited text no. 28
    
29.
Henriksen K, Adhami S. Patient experience of intravitreal injections in AMD. Int J Ophthalmic Pract 2010;1:68-72.  Back to cited text no. 29
    
30.
Fallor M, Mirza R, Lyon AT, Jayaram A, Gill M. Patient perspectives of anti-VEGF intravitreal injections. Investig Ophthalmol Visual Sci 2014;55:172.  Back to cited text no. 30
    
31.
Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C, Rees G. Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychol Health Med 2018;23:127-40.  Back to cited text no. 31
    
32.
Amoaku WM, Gale RP, Lotery AJ, Menon G, Sivaprasad S, Petrillo J, et al. Treatment satisfaction and well-being in patients with myopic choroidal neovascularization treated with ranibizumab in the REPAIR study. PLoS One 2015;10:e0128403.  Back to cited text no. 32
    
33.
Hasan H, Flockhart S, Qureshi W, Khan S, Ahmed S, Shah N. Intravitreal injections service: A patient experience evaluation. Br J Nurs 2017;26:678-82.  Back to cited text no. 33
    
34.
Rodríguez Ramírez M, del Barrio Manso MI, Martín Sánchez MD. Intravitreal injections: What do patients prefer? Analysis of patient's satisfaction and preferences about where to perform intravitreal injections. Arch Soc Esp Oftalmol 2014;89:477-83.  Back to cited text no. 34
    
35.
Marmor RA, Clay B, Millen M, Savides TJ, Longhurst CA. The Impact of Physician EHR Usage on Patient Satisfaction. Appl Clin Inform 2018;9:11-4.  Back to cited text no. 35
    
36.
Michtalik HJ, Yeh HC, Pronovost PJ, Brotman DJ. Impact of attending physician workload on patient care: A survey of hospitalists. JAMA Intern Med 2013;173:375-7.  Back to cited text no. 36
    
37.
Wali RM, Alqahtani RM, Alharazi SK, Bukhari SA, Quqandi SM. Patient satisfaction with the implementation of electronic medical Records in the Western Region, Saudi Arabia, 2018. BMC Fam Pract 2020;21:37.  Back to cited text no. 37
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Methods
Results
Discussion
References
Article Tables

 Article Access Statistics
    Viewed200    
    Printed12    
    Emailed0    
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]